# Controlled Ovarian Hyperstimulation (COH) With Sequential HPFSH & HMG Versus Rec-F.S.H Alone in ICSI Cycle

> **NCT04539613** · — · UNKNOWN · sponsor: **Alaa Fouli Gaber Ebrahim** · enrollment: 100 (estimated)

## Conditions studied

- Ovarian Stimulation in ICSI

## Interventions

- **DRUG:** HPFSH & HMG

## Key facts

- **NCT ID:** NCT04539613
- **Lead sponsor:** Alaa Fouli Gaber Ebrahim
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-01
- **Primary completion:** 2021-01-01
- **Final completion:** 2021-02-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04539613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04539613, "Controlled Ovarian Hyperstimulation (COH) With Sequential HPFSH & HMG Versus Rec-F.S.H Alone in ICSI Cycle". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04539613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*